REMSleep Holdings

RMSL · OTC

$0.0019+$0.0005 (+35.71%)TodayMarket closed ·
Prev close $0.0014

About RMSL

RemSleep Holdings, Inc. engages in the design and manufacture of medical devices and products for the treatment of sleep apnea and other respiratory conditions. The company is headquartered in Clearwater, Florida and currently employs 2 full-time employees. The company went IPO on 2008-12-15. The Company’s focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. Its patented DeltaWave product is a nasal-pillow type interface that is designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. DeltaWave delivers comfort and airflow for better sleep and improved CPAP therapy. The Company’s product is manufactured by mold makers. The company has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.

Employees
2
Headquarters
Clearwater, Florida
Listed
Dec 15, 2008
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

REMSleep Holdings executives
NameTitleSince
Anita Michaels—2026
Jeffrey Marshall—2026
Jonathan Lane—2019
Alexander Johnson——

Similar companies

Companies in the same industry as REMSleep Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.